NCT02656056View on ClinicalTrials.gov

Assessing the Role of a Fermented Soy Extract in Inflammation and the Human Microbiome

PHASE1CompletedINTERVENTIONAL
Enrollment

22

Participants

Timeline

Start Date

January 31, 2016

Primary Completion Date

June 30, 2017

Study Completion Date

June 30, 2017

Conditions
Obesity
Interventions
OTHER

Food: (Q-Can Plus fermented soybean beverage)

Fermented soybean beverage. Dose is 8 oz, twice daily.

Trial Locations (1)

06519

Yale University, New Haven

All Listed Sponsors
collaborator

BESO Biological Research, Inc.

UNKNOWN

lead

Yale University

OTHER

NCT02656056 - Assessing the Role of a Fermented Soy Extract in Inflammation and the Human Microbiome | Biotech Hunter | Biotech Hunter